Back to Trades
Grant4
Denali Therapeutics Inc.
DNLI
Total Value
$3.9M
Company Information
- Company Name
- Denali Therapeutics Inc.
- Ticker Symbol
- DNLI
- CIK
- 0001714899
Insider Information
- Name
- Watts Ryan J.
- Role
- President and CEO, Director
- Location
- SOUTH SAN FRANCISCO, CA
Filing Details
- Filing Date
- Jan 5, 2026
- Transaction Date
- Jan 3, 2026
- Accession Number
- 0001724310-26-000001
- Form Type
- 4